China SXT Pharmaceuticals Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.1114
- Today's High:
- $0.1162
- Open Price:
- $0.1146
- 52W Low:
- $0.105
- 52W High:
- $1.18
- Prev. Close:
- $0.118
- Volume:
- 1579982
Company Statistics
- Market Cap.:
- $1.66 million
- Book Value:
- 1.285
- Revenue TTM:
- $1.97 million
- Operating Margin TTM:
- -266.68%
- Gross Profit TTM:
- $1.25 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -10.42%
- Return on Equity TTM:
- -38.15%
Company Profile
China SXT Pharmaceuticals Inc had its IPO on 2019-01-04 under the ticker symbol SXTC.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. China SXT Pharmaceuticals Inc has a staff strength of 78 employees.
Stock update
Shares of China SXT Pharmaceuticals Inc opened at $0.11 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.11 - $0.12, and closed at $0.12.
This is a -1.61% slip from the previous day's closing price.
A total volume of 1,579,982 shares were traded at the close of the day’s session.
In the last one week, shares of China SXT Pharmaceuticals Inc have slipped by -1.61%.
China SXT Pharmaceuticals Inc's Key Ratios
China SXT Pharmaceuticals Inc has a market cap of $1.66 million, indicating a price to book ratio of 0.0949 and a price to sales ratio of 0.6231.
In the last 12-months China SXT Pharmaceuticals Inc’s revenue was $1.97 million with a gross profit of $1.25 million and an EBITDA of $-5007957. The EBITDA ratio measures China SXT Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, China SXT Pharmaceuticals Inc’s operating margin was -266.68% while its return on assets stood at -10.42% with a return of equity of -38.15%.
In Q2, China SXT Pharmaceuticals Inc’s quarterly earnings growth was a positive 42.6% while revenue growth was a negative 51.5%.
China SXT Pharmaceuticals Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.82 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into China SXT Pharmaceuticals Inc’s profitability.
China SXT Pharmaceuticals Inc stock is trading at a EV to sales ratio of 1.9496 and a EV to EBITDA ratio of 2.4477. Its price to sales ratio in the trailing 12-months stood at 0.6231.
China SXT Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $29.55 million
- Total Liabilities
- $14.50 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $1.03 million
- Dividend Payout Ratio
- 0%
China SXT Pharmaceuticals Inc ended 2024 with $29.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $29.55 million while shareholder equity stood at $14.69 million.
China SXT Pharmaceuticals Inc ended 2024 with $0 in deferred long-term liabilities, $14.50 million in other current liabilities, 913785.00 in common stock, $-21613133.00 in retained earnings and $0 in goodwill. Its cash balance stood at $17.37 million and cash and short-term investments were $17.37 million. The company’s total short-term debt was $3,390,897 while long-term debt stood at $0.
China SXT Pharmaceuticals Inc’s total current assets stands at $19.52 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.58 million compared to accounts payable of $1.38 million and inventory worth $531254.00.
In 2024, China SXT Pharmaceuticals Inc's operating cash flow was $0 while its capital expenditure stood at $1.03 million.
Comparatively, China SXT Pharmaceuticals Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.12
- 52-Week High
- $1.18
- 52-Week Low
- $0.105
- Analyst Target Price
- $
China SXT Pharmaceuticals Inc stock is currently trading at $0.12 per share. It touched a 52-week high of $1.18 and a 52-week low of $1.18. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.17 and 200-day moving average was $0.33 The short ratio stood at 0.11 indicating a short percent outstanding of 0%.
Around 479.6% of the company’s stock are held by insiders while 38.2% are held by institutions.
Frequently Asked Questions About China SXT Pharmaceuticals Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.